{"date":"2026-06-16","count":52,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4744-2026-06-16-1946-purmk1","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:46:58","subject":"公告本公司接獲佶恆實業股份有限公司等人向智慧財產及商業法院提出定暫時狀態處分暨緊急處置之聲請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-06-16 19:46，「公告本公司接獲佶恆實業股份有限公司等人向智慧財產及商業法院提出定暫時狀態處分暨緊急處置之聲請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-16-1914-7w42fs","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:14:51","subject":"公告本公司115年股東常會通過解除公司新任董事之競業禁止案","clause":"第21款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-16 19:14，「公告本公司115年股東常會通過解除公司新任董事之競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-16-1914-19hod7u","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:14:31","subject":"公告本公司臨時董事會選任董事長","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-16 19:14，「公告本公司臨時董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-16-1914-g3ti8q","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:14:11","subject":"公告本公司臨時董事會重要決議事項","clause":"第53款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-16 19:14，「公告本公司臨時董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-16-1913-1tyhvy","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:13:46","subject":"公告本公司115年股東常會董事及獨立董事全面改選當選名單","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-16 19:13，「公告本公司115年股東常會董事及獨立董事全面改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-16-1912-1jb8ii5","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"19:12:41","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-16 19:12，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-16-1816-z6rxem","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"18:16:59","subject":"公告本公司股票初次上櫃前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-16 18:16，「公告本公司股票初次上櫃前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-06-16-1816-1nuha4r","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"18:16:27","subject":"公告本公司最近一年累積處分有價證券達公告標準","clause":"第20款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-06-16 18:16，「公告本公司最近一年累積處分有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-16-1815-19di63w","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"18:15:30","subject":"公告本公司115年股東常會通過解除本公司董事及其代表人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-16 18:15，「公告本公司115年股東常會通過解除本公司董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-16-1814-1jb8ii5","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"18:14:02","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-16 18:14，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1811-j6qd15","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:11:56","subject":"公告本公司新建自動化智慧物流中心及預留未來產線廠房建置案","clause":"第20款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:11，「公告本公司新建自動化智慧物流中心及預留未來產線廠房建置案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1810-ixinhg","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:10:10","subject":"代重要子公司SUNETIC BIOTECH INC.股東常會重要決議事項公告","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:10，「代重要子公司SUNETIC BIOTECH INC.股東常會重要決議事項公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1809-yo6i39","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:09:45","subject":"代重要子公司SUNETIC BIOTECH INC.董事會公告決議股利分派事宜","clause":"第14款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:09，「代重要子公司SUNETIC BIOTECH INC.董事會公告決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1809-1n71h8x","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:09:16","subject":"代重要子公司杏輝天力(杭州)藥業有限公司董事會公告決議股利分派事宜","clause":"第14款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:09，「代重要子公司杏輝天力(杭州)藥業有限公司董事會公告決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1808-9od6gy","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:08:49","subject":"公告本公司董事會決議除息基準日暨現金股利發放日","clause":"第14款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:08，「公告本公司董事會決議除息基準日暨現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1806-ma6pel","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:06:39","subject":"公告本公司發言人、財務主管異動","clause":"第8款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:06，「公告本公司發言人、財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-06-16-1806-na4vgy","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"18:06:00","subject":"公告本公司股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-06-16 18:06，「公告本公司股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-06-16-1801-kpc8km","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"18:01:15","subject":"衛福部核准台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院紀念醫院與本公司合作之「自體脂肪幹細胞治療慢性或滿六週未癒合之困難傷口」細胞治療技術施行計畫","clause":"第53款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-06-16 18:01，「衛福部核准台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院紀念醫院與本公司合作之「自體脂肪幹細胞治療慢性或滿六週未癒合之困難」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-06-16-1737-om6vk9","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"17:37:38","subject":"公告本公司董事會決議第二次買回庫藏股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-06-16 17:37，「公告本公司董事會決議第二次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-06-16-1732-rwgt0m","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"17:32:55","subject":"公告本公司一一五年股東常會通過解除部分董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-06-16 17:32，「公告本公司一一五年股東常會通過解除部分董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-06-16-1728-1dfxd4q","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"17:28:58","subject":"公告本公司一一五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-06-16 17:28，「公告本公司一一五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-16-1658-hk2f6k","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"16:58:31","subject":"公告本公司買回庫藏股執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-16 16:58，「公告本公司買回庫藏股執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1652-1fb22c","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:52:32","subject":"公告本公司董事會決議委任第五屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:52，「公告本公司董事會決議委任第五屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1650-1j7u2pb","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:50:57","subject":"公告本公司第五屆審計委員會委員","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:50，「公告本公司第五屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1649-s0kpz3","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:49:45","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:49，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1648-16106y9","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:48:39","subject":"公告本公司115年股東常會通過解除董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:48，「公告本公司115年股東常會通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1646-1uo5eyd","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:46:07","subject":"公告本公司115年股東常會改選董事名單","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:46，「公告本公司115年股東常會改選董事名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-06-16-1644-1jb8ii5","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:44:07","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-06-16 16:44，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-06-16-1639-1ykvrff","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"16:39:42","subject":"代重要子公司台灣永生公告業務副總職務異動","clause":"第8款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-06-16 16:39，「代重要子公司台灣永生公告業務副總職務異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-06-16-1631-v1rvzv","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"16:31:43","subject":"代孫公司馬光國際開發股份有限公司公告處分有價證券達實收資本額20%","clause":"第20款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-06-16 16:31，「代孫公司馬光國際開發股份有限公司公告處分有價證券達實收資本額20%」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-06-16-1626-1jb8ii5","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"16:26:06","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-06-16 16:26，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-06-16-1615-1jb8ii5","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:15:49","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-06-16 16:15，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-06-16-1608-1jb8ii5","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"16:08:48","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-06-16 16:08，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-06-16-1600-130uihy","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"16:00:06","subject":"公告本公司卡前列素氨丁三醇注射液(Carboprost TromethamineInjection)取得沙烏地阿拉伯食品藥物管理局正式核准","clause":"第44款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-06-16 16:00，「公告本公司卡前列素氨丁三醇注射液(Carboprost TromethamineInjection)取得沙烏地阿拉伯食品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-06-16-1551-1qybse2","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:51:09","subject":"公告本公司董事會授權董事長訂定除權暨增資基準日相關事宜","clause":"第44款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-06-16 15:51，「公告本公司董事會授權董事長訂定除權暨增資基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1550-5rtnb8","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:50:12","subject":"本公司第三屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:50，「本公司第三屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1549-o1mt01","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:49:42","subject":"本公司全面改選董事後，董事會推舉董事長","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:49，「本公司全面改選董事後，董事會推舉董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1549-beqmt","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:49:21","subject":"本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:49，「本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1548-dr0vq4","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:48:25","subject":"本公司115年股東常會通過解除新任董事(含獨立董事)及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:48，「本公司115年股東常會通過解除新任董事(含獨立董事)及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-06-16-1548-6uifat","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:48:13","subject":"公告董事會通過新任財務長（暨兼任會計主管及代理發言人）委任案","clause":"第11款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-06-16 15:48，「公告董事會通過新任財務長（暨兼任會計主管及代理發言人）委任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1547-6c9poe","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:47:58","subject":"本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:47，「本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-06-16-1547-15e1v8f","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:47:17","subject":"本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-06-16 15:47，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-06-16-1544-1jb8ii5","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-06-16","time":"15:44:43","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-06-16 15:44，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-06-16-1525-1r5vl9v","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"15:25:30","subject":"更正6/12公告本公司召開重大訊息說明記者會新聞稿內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-06-16 15:25，「更正6/12公告本公司召開重大訊息說明記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-06-16-1511-1fd3vqc","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"15:11:34","subject":"115年股東常會通過解除董事競業禁止限制案","clause":"第21款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-06-16 15:11，「115年股東常會通過解除董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-06-16-1509-ssvo5d","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"15:09:47","subject":"115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-06-16 15:09，「115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2026-06-16-1422-zxfqmi","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2026-06-16","time":"14:22:28","subject":"慧智基因受邀參加福邦證券所舉辦之法人說明會","clause":"第12款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2026-06-16 14:22，「慧智基因受邀參加福邦證券所舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-06-16-1420-r778mz","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"14:20:54","subject":"公告本公司中華民國境內第二次無擔保轉換公司債轉換價格調整","clause":"第51款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-06-16 14:20，「公告本公司中華民國境內第二次無擔保轉換公司債轉換價格調整」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-06-16-1417-qx98f0","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"14:17:14","subject":"本公司生物相似性藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 420 mg)」自7月1日起獲核准擴增健保給付範圍","clause":"第51款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-06-16 14:17，「本公司生物相似性藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 420 mg)」自7月1日起獲核准擴增健」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-06-16-1408-lewzru","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"14:08:05","subject":"公告本公司2026年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-06-16 14:08，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-16-1143-cr5gmb","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"11:43:48","subject":"公告本公司115年股東常會決議解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-16 11:43，「公告本公司115年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-16-1142-1jb8ii5","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-16","time":"11:42:54","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-16 11:42，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}